Use of melatonin supplements and risk of type 2 diabetes and cardiovascular diseases in the USA: insights from three prospective cohort studies.
Li Y, Huang T, Redline S, Willett WC, Manson JE, Schernhammer ES, Hu FB.
Lancet Diabetes Endocrinol. 2024 Jun. 12(6):404-413. PMID: 38710189